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Cytochrome P450 oxidoreductase (POR) is the obligate electron donor for all microsomal cytochrome P450
enzymes, which catalyze the metabolism of a wide spectrum of xenobiotic and endobiotic compounds. Point
mutations in POR have been found recently in patients with Antley-Bixler-like syndrome, which includes limb
skeletal defects. In order to study P450 function during limb and skeletal development, we deleted POR
specifically in mouse limb bud mesenchyme. Forelimbs and hind limbs in conditional knockout (CKO) mice
were short with thin skeletal elements and fused joints. POR deletion occurred earlier in forelimbs than in hind
limbs, leading additionally to soft tissue syndactyly and loss of wrist elements and phalanges due to changes
in growth, cell death, and skeletal segmentation. Transcriptional analysis of E12.5 mouse forelimb buds
demonstrated the expression of P450s involved in retinoic acid, cholesterol, and arachidonic acid metabolism.
Biochemical analysis of CKO limbs confirmed retinoic acid excess. In CKO limbs, expression of genes
throughout the whole cholesterol biosynthetic pathway was upregulated, and cholesterol deficiency can explain
most aspects of the phenotype. Thus, cellular POR-dependent cholesterol synthesis is essential during limb
and skeletal development. Modulation of P450 activity could contribute to susceptibility of the embryo and
developing organs to teratogenesis.
The P450 system is best characterized for its role in the
metabolism and detoxification of environmental chemicals in
adult liver (57). However, some subfamilies of P450 enzymes
also have a pivotal role in metabolizing endogenous com-
pounds such as hormones and fatty acids (4, 63). Cytochrome
P450 oxidoreductase (POR) is the obligate electron donor for
all microsomal cytochrome P450 enzymes (Cyps) and, in the
absence of POR, these enzymes are catalytically inactive (3).
There are more than 100 P450 enzymes in mice and over 50 in
humans, and the particular profiles of P450s, many of which
are polymorphic, determine an individual’s response to drugs
(58, 59). Surprisingly, however, rather little is known about the
function of these enzymes in embryonic development, al-
though the recent discovery of point mutations in POR in
patients with Antley-Bixler-like syndrome is direct evidence of
their importance during human development (27, 29).
Several studies have shown that POR and genes encoding
P450 enzymes are expressed in mouse embryos. POR expres-
sion has been detected from preimplantation stages onward
(81), while the most comprehensive studies of expression of
cytochrome P450s have revealed that genes encoding several
of these enzymes are temporally regulated over four stages of
development (13, 14); temporal regulation has also been
shown for Cyp1A1 in more detail (7). These P450 studies,
however, were based on reverse transcription-PCR and did not
give any information about tissue localization.
Deletion of individual P450 genes in mice has uncovered
some essential developmental roles. Members of the Cyp26
subfamily of P450s are involved in degrading retinoic acid, an
important signal in the development of many parts of the
embryo. Retinoic acid concentration in embryos is regulated
via a feedback mechanism (19, 66), with production and deg-
radation of retinoic acid taking place in complementary do-
mains (83). Deletion of Cyp26 genes leads to increased levels
of retinoic acid and developmental defects (70, 96). In addi-
tion, cholesterol, synthesized by Cyp51 and metabolized by
other Cyp family members to produce steroid hormones and
vitamin D (56, 65), is known to be essential for normal devel-
opment (69).
Another approach that has been taken to understand the
essential role of the P450 system in embryonic development
has been the deletion of POR and, as a consequence, the
removal of all microsomal P450 function. This approach avoids
problems with multiplicity and functional redundancy of Cyp
enzymes. POR deletion in mice leads to elevated retinoic acid
levels and embryonic lethality prior to organogenesis and limb
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initiation, implicating retinoic acid metabolism as the major
P450 pathway (64, 67) downstream of POR function in the
early embryo. When retinoic acid levels were reduced either by
feeding POR-deficient mice with a retinoid-deficient diet (64)
or, genetically, by crossing them with mice haploinsufficient for
the retinoic acid-generating enzyme Raldh2 (67), embryonic
development improved, some PORlox/lox; Raldh2lacZ/ embryos
surviving until embryonic day 13.5 (E13.5). Knockout of the
membrane-binding domain of POR (75) also resulted in longer
survival.
We have focused here on the P450 system in limb develop-
ment. The limb is one of the best-studied organ systems in
vertebrate embryos and a well-known target for teratogens.
POR has been reported to be expressed in E12.5 mouse limb
mesenchyme and later, at E13.5, at high levels in joint-forming
regions and perichondrium (43). Limb buds in PORlox/lox;
Raldh2lacZ/ embryos surviving until E13.5 had anteroposte-
rior patterning defects (68), and limb buds in embryos in which
the membrane domain of POR was knocked out were de-
scribed as abnormal (75). Furthermore, some patients with
POR mutations have defects in the limb skeleton (29). We
generated a conditional knockout mouse line by crossing Prx1-
Cre mice (51) to mice in which both alleles of POR are flanked
by loxP sites (36). The Prx1-Cre mouse line has been widely
used to knock out genes specifically in limb bud mesenchyme
cells, which give rise to the skeleton and other connective
tissues (1, 15, 49, 84). Gene knockout has been reported to
occur at E9.5 in forelimb buds but slightly later in hind limb
buds (51). This conditional approach creates a peripheral dys-
function, thus avoiding the embryonic lethality of a systemic
POR knockout.
We found that POR deletion in mouse limb buds leads to
defects in both patterning and skeletogenesis. Microarray anal-
ysis suggested the involvement of P450 pathways participating
in retinoic acid, cholesterol, and arachidonic acid metabolism.
All trans-retinoic acid was elevated, while cholesterol was re-
duced in CKO limbs. Most aspects of the Prx1-Cre; PORlox/lox
limb phenotype can be explained by cholesterol deficiency.
MATERIALS AND METHODS
Animal husbandry. PORlox/lox mice (C57BL/6; N6) were crossed with a trans-
genic mouse line [Tg(Prrx1-Cre)1Cjt] expressing Cre recombinase under the
control of the Prx1 promoter (Prx1-Cre) on a C57BL/6 background (51). Prx1-
Cre; PORlox/ offspring were backcrossed with PORlox/lox mice to generate limb-
specific POR knockout (Prx1-Cre; PORlox/lox) and control (wildtype; PORlox/lox)
mice. Presence of the Prx1-Cre transgene was determined by PCR using 5-AC
CTGAAGATGTTCGCGATTATCT-3 and 5-ACCGTCAGTACGTGAGAT
ATCTT-3. The floxed status of the POR gene was determined by PCR as
previously described (36).
All mice were maintained under standard animal house conditions, with free
access to food and water, and 12-h/12-h light-dark cycle. Mice were fed ad
libitum on standard Rat & Mouse #1 maintenance diet or, alternatively, on
special diets: a vitamin A-deficient (VAD) diet, a diet supplemented with 2%
(wt/wt) cholesterol, or a combination of the two (Special Diets Services, Witham,
Essex, United Kingdom). All mouse work was carried out in accordance with the
Animal Scientific Procedures Act of 1986 and after local ethical review.
Scanning electron microscopy, micro-computed tomography (CT), and mi-
cro-magnetic resonance imaging (MRI). For scanning electron microscopy,
E13.5 embryos were fixed in 2.5% glutaraldehyde at 4°C overnight, postfixed in
1% OsO4 in cacodylate buffer, dehydrated in graded ethanol, placed in acetone,
critically point dried, and sputter coated with gold/palladium. Forelimbs were
dissected off and viewed on a Philips XL30 emission scanning electron micro-
scope.
CT was carried out by using a Skyscan 1072 X-ray microtomograph (Skyscan,
Aartselaar, Belgium). Paraformaldehyde-fixed forelimbs were wrapped in
Parafilm (American National Can, Chicago, IL) to prevent dehydration and
mounted in the CT vertically with the proximal end uppermost. Prior to scan-
ning, the magnification was adjusted so the larger paw (from control) was con-
tained within the field of view. This magnification was then maintained while
scanning CKO limbs. The CT scanner settings were as follows: pixel size, 7.32
m; source, 50 kV/197 A; rotation, 180°; rotation step, 0.68°; exposure time, 6 s;
gain, 1.0; averaging, 1; flat field correction, on; random movement, 10; and filter,
Al 0.5 mm.
Data for the MRI images showing all tissue types were collected using a
standard three-dimensional (3D) spin-echo sequence. 3D surface-rendered im-
ages were produced showing both the surface of the limb and the distribution of
lipid within. A second acquisition sequence that suppressed the lipid signal was
used to confirm the identification of the lipid. The data for images were accu-
mulated on a Bruker Avance FT nuclear magnetic resonance spectrometer with
a 7.1T wide bore vertical magnet resonating at 300 MHz for 1H. The spectrom-
eter was fitted with a Bruker microimaging accessory and probe equipped with a
25-mm birdcage resonator. The data were acquired using pulse sequences from
the Bruker Paravision library (m_se3d, 3D spin-echo; m_suppress, 3D spin-echo
with lipid suppression). For all samples, the probe was tuned and the magnet was
shimmed before data acquisition. Four acquisition sequences were collected and
averaged to improve the signal-to-noise ratio and remove artifacts. The acqui-
sition parameters were as follows: matrix size, 256 by 256 by 256; field of view,
30.0 by 30.0 by 30.0 mm; and voxel dimensions, 120 by 120 by 120 m. Imaging
data were Fourier transformed, and then transferred to a PC for final visualiza-
tion using AMIRA imaging software (Mercury Computer Systems, Inc., TGS
unit, Whyteleafe, United Kingdom). A series of images was acquired using a
range of acquisition parameters; images described here were acquired using a
TR/TE of 300/25 ms. The AMIRA software allowed construction of pseudo 3D
surface rendered images, which could be viewed from any angle.
Western blotting, immunohistochemistry, and skeletal staining. POR detec-
tion in whole-limb protein extracts was carried out with a polyclonal antibody
raised to human POR (35). For anti-pH3 staining, sections were blocked with
10% fetal calf serum–1% bovine serum albumin in phosphate-buffered saline,
incubated with primary antibody (1:100; Upstate, New York, NY) and detected
with anti-rabbit-Alexa 488 (1:200; Molecular Probes, The Netherlands). Fluo-
rescent images were taken with a Genoptic C14 camera on a Leica MZ Fluo3
microscope and processed with Openlab 4.1 and Adobe Photoshop CS2. Ante-
rior of the limb bud is up and posterior is down in all images. Samples for
histology were fixed in 4% paraformaldehyde for several days and processed
according to standard staining protocols. Alcian Blue and Alizarin Red staining
for cartilage and bone, respectively, was carried out as published previously (54),
and limbs were measured under a binocular microscope with a vernier caliper.
TUNEL stain and in situ hybridization. TUNEL (terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick end labeling) staining was performed
according to the manufacturer’s instructions on 14-m frozen sections (in situ
cell death detection kit fluorescein; Roche, Germany).
Whole-mount in situ hybridizations were carried out as described previously
(67). Riboprobes were either cloned or kindly provided by Se-Jin Lee (GDF5),
Robert Hill (Msx2), Klaus van de Mark (Col2A and Col10), Michael Wegner (Ihh
and Sox9), Tomoko Iwata (Patched1), Andrea Vortkamp (Gli1), Brigid Hogan
(FoxC1), Pascal Dolle´ (Raldh2), and Denis Duboule (HoxD probes). Images
were taken and processed as described above. In situ hybridizations were carried
out on three independent samples with little variability in the results, unless
stated otherwise.
Whole-mount limb buds of Cyp26B1 and Raldh2 in situ hybridization experi-
ments were processed and scanned by using optical projection tomography (74).
3D reconstruction of data was performed using AMIRA software.
Retinoid and sterol quantification. After genotyping, forelimb and hind limb
buds of four E12.5 embryos were pooled separately to give single samples for
forelimb buds and hind limbs, respectively. Pools were made from both normal
and CKO embryos. Pooled limb buds (three pools) were homogenized in ice-cold
phosphate-buffered saline with a motorized homogenizer (Pro Scientific, Inc.,
Oxford, CT), and retinoids were extracted with ice-cold 2-propanol containing
13C-labeled all-trans retinoic acid (atRA) as an internal standard. An aliquot was
injected into a 4000 Q TRAP LC-MS/MS instrument with APCI ionization
(Applied Biosystems, California). The liquid chromatography-mass spectrometry
conditions were as described previously (33), except that the separating column
was an ABZ Plus (75 by 3 mm [inner diameter], 3-m particles; Supelco, Penn-
sylvania). The entire procedure was performed under red light.
For sterol quantifications, left and right limb buds of E13.5 genotyped embryos
were pooled to give single samples for forelimbs and hind limbs, respectively.
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Sample preparation and enzymatic assays were performed according to the
manufacturer’s instructions (cholesterol quantification kit; Biovision, California).
For lipid analysis, tissue samples were prepared, weighed, and frozen on dry
ice-ethanol. The lipid extraction method was adapted from that of a previous
study (28) and carried out at the Mylnefield Lipid Analysis, Scottish Crop
Research Institute, Invergowrie, United Kingdom. Briefly, chloroform–metha-
nol–0.88% KCl (2:1:0.8 [vol/vol/vol]) was used for extraction, and the samples
were washed with 0.88% potassium chloride-methanol (1:1 [vol/vol]). Oil content
was calculated as an average of seven animals each and is expressed as a per-
centage from milligrams of oil per gram of tissue. For standard esterification,
followed by gas chromatography, the American Oil Chemist Society official
method (“Ce1b-89: Fatty Acid Composition by GLC, Marine Oils”) was used.
Mean values (three mice each) in percentages are given for cholesterol and
lathosterol, with total sterol normalized to 100%.
Microarray analysis. Total RNA was extracted with TRIzol (Life Technolo-
gies, United Kingdom) according to the manufacturer’s guidelines, except for the
addition of 1 l of linear acrylamide (Ambion, Inc., Texas) at precipitation, from
pooled, genotyped E12.5 forelimb buds (four limb buds per pool). Five pools of
control and five pools of CKO forelimb total RNA were prepared. Microarray
analysis was carried out using standard protocols on Genechip Mouse 430 2.0
arrays (Affymetrix, United Kingdom). Amplified RNA was prepared from 5 g
of total RNA by using a GeneChip 3 expression one cycle target labeling kit
(Affymetrix) according to the manufacturer’s recommendations. After overnight
hybridization, arrays were processed using the Affymetrix fluidics station. Ob-
tained images were processed with GCOS software, and the resulting CEL files
were analyzed. Normalization of experimental data was done with Expression
Console software (Affymetrix) using the PLIER algorithm.
Statistical analysis was carried out using the LIMMA (76) module in Biocon-
ductor software (31). Differences between CKO and the control condition were
examined by a modified t test, where the LIMMA eBayes correction was used to
produce a moderated T-statistic, thereby shrinking estimated sample variances
toward a pooled estimate, resulting in far more stable inference. The top 50
transcripts with the lowest false discovery rate were annotated using NetAffx
website (http://www.affymetrix.com/analysis/index.affx) and subjected to pathway
analysis with GenMAPP software (18). The complete data set is available at
http://www.ebi.ac.uk/arrayexpress (E_TABM_367).
RESULTS
Conditional deletion of POR leads to limb malformations. In
order to investigate POR function specifically in the develop-
ing limb bud and skeleton, we generated a conditional knock-
out mouse line, Prx1-Cre; PORlox/lox (CKO), by crossing Prx1-
Cre mice (51) to mice with both alleles of POR flanked by loxP
sites (36). We monitored POR knockout at both transcript and
protein level in limb buds of Prx1-Cre; PORlox/lox embryos (Fig.
1). POR transcripts were absent and POR protein was moder-
ately reduced at E10.5 and undetectable at E11.5 in forelimb
buds (compare Fig. 1C to A; Fig. 1I), whereas, in hind limb
buds, POR transcripts and protein were present at E10.5, and
the protein was still faintly detectable at E11.5 (compare Fig.
1H to F; Fig. 1I).
The conditional deletion of POR during limb bud devel-
opment resulted in limb malformations. In 7 day Prx1-Cre;
PORlox/lox mice, the limbs were clearly abnormal (Fig. 2A),
with forelimbs being much shorter and more malformed than
hind limbs (57% of the length of control forelimbs and 79% of
FIG. 1. Timing of POR knockout in limb buds of Prx1-Cre; PORlox/lox
mice. In situ hybridization with a POR-specific probe on limb buds at
E10.5 (A to D) and E11.5 (E to H). No signal was detected in CKO
forelimb buds at E10.5 (compare panels A and C). POR deletion in
hind limb buds occurs later at E11.5 (compare panels F and H).
(I) Detection of POR protein in whole-limb protein extracts. POR
protein was markedly reduced in E10.5 forelimb buds of CKO mice
and undetectable at E11.5 in forelimb buds but faintly present in hind
limb buds. -Tubulin was used as a loading control. Representative
images of two independent Western blot analyses are shown.
FIG. 2. Phenotypic characterization of 1-week-old Prx1-Cre; PORlox/lox forelimbs and hind limbs. (A) External view of CKO mouse and control
littermate. Insets show dorsal view of forepaws; an arrowhead indicates splayed digits. Note the shorter forelimbs (arrowed) and overall size
reduction. (B) Cartilage (Alcian Blue) and bone (Alizarin Red) staining of forelimbs and hind limbs. CKO forelimbs are shorter and have only
two carpal bones (compare insets), no secondary ossification centers (open arrowhead), and a reduced number of phalanges in digits 1, 2, and 5
(stars). Processes on humerus and femur (arrows) are missing or reduced. CKO forepaws show characteristic splaying of digits 3 and 4 (arrowhead).
Abbreviations: A, autopod; Fe, femur; Fi, fibula; Hu, humerus; Ra, radius; S, stylopod; Ti, tibia; Ul, ulna; Z, zeugopod.
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control hind limbs, respectively). This difference in severity of
the defects is consistent with the difference in developmental
timing of knockout with POR being deleted at an earlier stage
in the forelimb compared to the hind limb. More detailed
external examination of the forelimbs also revealed that the
digits appeared stunted and fused except for a pronounced
interdigital space between digits 3 and 4 (Fig. 2A, compare
insets).
Skeletal preparations of the limbs of 7 day Prx1-Cre; PORlox/lox
mice showed that all bones were short and misshapen in both
forelimbs and hind limbs with forelimb elements again more
affected than those in hind limbs (Fig. 2B; see Table S1 in the
supplemental material for measurements of the lengths of in-
dividual bones in forelimbs and hind limbs and details of skel-
etal phenotype analysis). Long bones in the stylopod (upper
part of the limb, i.e., humerus in forelimb and femur in hind
limb; Fig. 2B) and zeugopod (middle part of the limb, i.e.,
radius and ulna in the forelimb and tibia and fibula in the hind
limb, Z in Fig. 2B) were thinner. Processes on humerus and
femur were reduced or absent (Fig. 2B), no secondary ossifi-
cation centers were seen (Fig. 2B) and in the hind limbs, the
fibula was very bent and tibia and fibula were not fused (Fig.
2B). In addition, joints, especially at the knee and elbow, were
malformed and swollen and, in about half of the CKO fore-
paws, fusion of digits and joints was noted (see Table S1 in the
supplemental material). No skeletal patterning defects were
seen in CKO hind limbs, but in CKO forelimbs digits 1, 2, and
5 lacked one phalange each (Fig. 2B), and six out of eight
carpal bones were absent, leaving most likely hamate and cen-
tral carpal bones (Fig. 2B, compare insets). The characteristic
splaying of digits 3 and 4 in the forelimb was also clear in the
skeletal preparations (Fig. 2B).
Postnatal consequences of functionally inactivating POR in
the limbs were monitored over 2 months. The growth of both
forelimbs and hind limbs was impaired with the forelimb con-
tinuing to be more affected (see Table 1 in the supplemental
material). Comparison of the mineralized tissue of CKO fore-
paws and those of control mice using CT showed that all
skeletal elements were much shorter and generally misshapen
in the CKO (Fig. 3A and B). The interdigital space between
digits 3 and 4 was still very marked. Joint fusion in the CKO
was already apparent at 7 days in half the animals studied (see
Table 1 in the supplemental material), and histological sections
through phalangeal joints at 2 months showed hyperprolifera-
tion of articular cartilage and fusion across the synovial cavity
(Fig. 3A and B, compare insets). In the soft tissue, a substantial
increase in lipid in the CKO paws could be visualized with
MRI by separating water and lipid resonances (Fig. 3C and
D). The spongy appearance of the tissue in histological sec-
tions of the proximal region of the CKO paws (Fig. 3F inset)
and the higher levels of extractable oil from the samples (Fig.
3C and D, values on the bottom) confirmed the lipid accumu-
lation. Comparison of normal and CKO in the interdigital
region highlighted spongelike tissue in regions where muscle
was normally present (see Fig. S1E and F in the supplemental
material), suggesting that lipid has accumulated in muscle.
Thus, at 2 months, functional inactivation of POR in the limb
has led to continued reduction in longitudinal growth and lipid
accumulation. Some of these changes could be secondary due
to the lack of normal usage of the limb.
Embryonic development of forelimb and skeleton in condi-
tional POR knockout mice. In order to identify critical events
leading to changes in Prx1-Cre; PORlox/lox mice, we followed
forelimb development during embryogenesis because POR is
deleted earlier in forelimbs than in hind limbs (Fig. 1), and this
leads to more marked skeletal defects and also to patterning
defects (Fig. 2B). At E10.5 and E11.5, stages at which POR
protein was markedly reduced or no longer detectable, respec-
tively (Fig. 1I), no change in the size and shape of forelimb
buds was observed (compare Fig. 1A to C and Fig. 1E to G).
External inspection of E12.5 forelimb buds (Fig. 4A and B)
also did not reveal major differences between control and Prx1-
Cre; PORlox/lox embryos, although CKO paws were slightly
stunted (Fig. 4B). Chondrogenic condensations were similar in
both genotypes (data not shown). In contrast, at E13.5, exter-
FIG. 3. Postnatal development of the phenotype. (A and B) CT
images of forepaws of 2-month-old mice. Dorsal view. Insets show
histological sections through intraphalangeal joints. The CKO digit has
malformed joints. (C and D) MRI images of 2-month-old forepaws.
A ventral view of the skeleton (darker purple) is shown; surface lipid
deposits are rendered in yellow. The inset shows a histological section
through a CKO paw confirming fat accumulation. Values given at the
bottom are expressed as milligrams of extracted oil per gram of tissue
(mean of seven mice each).
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nal changes were immediately obvious in CKO forelimbs (Fig.
4C and D), and these were accentuated at E14.5 (Fig. 4E and
F) and E17.5 (Fig. 4G and H). The outgrowth of digits in E14.5
Prx1-Cre; PORlox/lox limbs was reduced, as were indentations
between digits 1, 2, and 3 and between digits 4 and 5, leading
to soft tissue webbing especially involving digits 1, 2, and 3
(Fig. 4E and F). The indentation between digits 3 and 4,
however, still developed so that these digits splayed apart.
Alcian Blue staining at E14.5 also indicated delayed develop-
ment of interphalangeal joints compared to control limbs
(compare Fig. 4E and F, insets). In E17.5 CKO limbs, only
digits 3 and 4 were clearly separated (Fig. 4H, arrowhead), and
digits 1 to 3 appeared fused (Fig. 4H) due to soft tissue web-
bing (compare to Fig. 4G).
Skeletal preparations of E17.5 forelimbs not only showed
the characteristic splaying of digits 3 and 4 in the CKO but also
that stylo- and zeugopod were reduced in length and the hu-
meral process was absent (Fig. 4I and J), while in the paw, only
two carpal bones were present (Fig. 4J, inset, arrow, compare
to 4I, inset), and the phalanges of digits 1, 2, and 5 were not
fully segmented (Fig. 4J [compare to Fig. 4I]). Other postna-
tally obvious aspects of the phenotype had not yet appeared, in
particular thinning of the long bones and swollen joints.
Soft tissue webbing in CKO forelimbs suggested impairment
of interdigital cell death. In situ hybridizations on E12.5 limb
buds for Msx2 (71), a gene encoding a homeobox transcription
factor associated with interdigital preapoptotic cells, showed
that Msx2 expression was markedly reduced in all interdigital
spaces in CKO forelimbs except between digits 3 and 4 (com-
pare Fig. 5A and B). TUNEL assays performed on sections of
E13.5 limb buds confirmed reduced interdigital cell death be-
tween anterior digits although apoptosis appeared increased
subapically (Fig. 5C and D). A decrease in apoptosis in CKO
forelimb buds did not seem consistent with smaller paws, but
overall proliferation was also reduced, as shown by immuno-
staining against phosphorylated histone H3 (compare Fig. 5E
and F).
Another feature of Prx1-Cre; PORlox/lox forelimbs was failure
to complete digit segmentation, leading to loss of a phalanx in
digits 1, 2, and 5. In order to investigate phalanx segmentation,
the expression of GDF5, a gene encoding a transforming
growth factor  specifically expressed in joint-forming regions
of developing limb buds (79, 80), was examined. No difference
was detected at E12.5 between normal and CKO forelimb buds
(Fig. 5G and H). At E13.5, the time at which it has been
reported that POR is expressed at high levels in joint-forming
regions (43), GDF5 expression in CKO forelimbs was compa-
rable to controls in digits 3 and 4 even though these were
clearly reduced in length but compressed to one domain at
both edges of the handplate (Fig. 5I and J). At E14.5, the
handplate of Prx1-Cre; PORlox/lox limb buds appeared even
more stunted and GDF5 expression was generally increased
even in interdigital regions, making it difficult to define the
presumptive joints (Fig. 5K and L).
The patterning defect of missing wrist elements and phalan-
ges prompted an investigation of expression of HoxD11-
HoxD13 genes known to be involved in development of skeletal
elements in the distal limb (98, 99). No changes could be
detected at either E12.5 or even at E13.5 when CKO forelimb
buds were clearly misshapen (data not shown). Because pat-
terning of the anterior and posterior autopods was most af-
fected, Tbx3, normally expressed in anterior and posterior
stripes in developing limb buds and implicated in digit speci-
FIG. 4. External and skeletal phenotype of Prx1-Cre; PORlox/lox fore-
limb buds during embryogenesis. Embryonic ages are indicated on the
left, and genotypes are indicated across the top. (A, B, E, F, G, and H)
External dorsal views of fixed limb buds. At E12.5, CKO forelimbs are
slightly stunted (arrowhead). (C and D) Scanning electron microscopy of
E13.5 limb buds. Note the extended space between digits 3 and 4 (arrow-
heads) at E13.5 and E14.5 and the webbing in E17.5 CKO forelimbs (H,
star). (E and F, insets) Cartilage (in dark gray) staining of E14.5 forelimb
buds. (I and J) Cartilage and bone (in black) staining of E17.5 forelimbs.
Note the deeper indentation between digits 3 and 4 at E13.5, E14.5, and
E17.5 (arrowheads). At E17.5, two carpal bones are present (compare I
and J, insets, arrows); posterior and anterior digits are less well developed
(J, stars). Two or three limb buds were examined for each genotype with
little or no variation; for E17.5 at least five limb skeletons were stained,
and representative examples for each genotype are shown.
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fication (82, 86), was investigated, but again no difference in
gene expression was seen in the CKO (data not shown).
Chondrogenesis of forelimb skeleton in Prx1-Cre; PORlox/lox
mice. In order to investigate skeletal development in CKO
forelimbs in more detail, we assessed expression of Sox9 (Sry-
related HMG box 9), a gene encoding a transcription factor
required for mesenchymal condensation and chondrogenesis
(1, 93). Sox9 expression at E12.5 was very similar in forelimbs
of both, control and CKO embryos consistent with Alcian Blue
staining at this stage (data not shown) but by E13.5, Sox9
expression appeared broader in digits of CKO forelimbs with
less sharp boundaries and less definition around joint forming
regions (compare Fig. 6A and B). Branching of digit 2 primor-
dium was observed in one of three cases (Fig. 6B).
To study specific chondrogenic differentiation states, we ex-
amined the expression of Collagen 2A (Col2A), a transcrip-
tional target of Sox9 in proliferating chondrocytes (60), and
Indian hedgehog (Ihh) and Collagen 10 (Col10), expressed in
prehypertrophic and hypertrophic chondrocytes, respectively
(22, 87). Col2A was expressed throughout all digit primordia
similar to Sox9 at both E12.5 (not shown) and E13.5 (compare
Fig. 6A and B with Fig. 6C and D) with broader, less-well-
defined expression in CKO limb buds; in one of three cases
digit 2 was branched (Fig. 6D). Expression of Col10 and Ihh
was extended in the proximal region of middle digits, usually
digits 3 and 4 but virtually absent in anterior and posterior
digits (Fig. 6E to H). In contrast to all other gene expression
patterns investigated, Col10 and Ihh patterns appeared rather
variable in that the size and shape of expression domains
differed from embryo to embryo, e.g., more fan-shaped in one
and more rod-shaped and shorter in another.
Microarray analysis. In order to gain insights into how the
phenotype described above is related to function of POR and
P450 enzymes during mouse limb development, we performed
whole-genome expression analysis and evaluated the results of
an average of five arrays per genotype. Transcriptional changes
were investigated at E12.5, the time before marked morpho-
logical differences were obvious but at which there were al-
ready clear alterations in Msx2 expression.
A total of 60 mouse P450 genes have annotated probe sets
on the 3-expression array, and 14 out of these were found to
be expressed in E12.5 forelimb buds (Fig. 7A; according to
present calls in all five control arrays). For two, Cyp2d22 and
Cyp20a1, enzymatic substrates of their proteins are not yet
known. The gene encoding the retinoic acid metabolizing en-
zyme, Cyp26a1, was expressed (Fig. 7A, green). Another mem-
ber of this subfamily, Cyp26b1, was not represented on the
array but is known to be expressed in limb buds at this stage
(39, 70, 96). All other P450s present were involved in either
arachidonic acid (Fig. 7A, black) or cholesterol (Fig. 7A, red)
metabolism.
To identify gene expression changes in Prx1-Cre; PORlox/lox
forelimb buds, a statistical analysis of all differentially ex-
pressed genes was performed. Surprisingly, expression of only
0.1% of genes represented on the array was found to be sig-
nificantly changed with a low false discovery rate (Fig. 7B).
These top 50 probe sets represent 39 different genes. As ex-
pected, Msx2 was among downregulated transcripts (Fig. 7B
FIG. 5. Gene expression, proliferation, and apoptosis in Prx1-Cre; PORlox/lox forelimb buds. (A and B) In situ hybridization with a Msx2-specific
probe at E12.5. Expression of Msx2 is reduced in CKO limb buds (B), with the exception of the interdigital space between digits 3 and 4 matching
the observed phenotype. (C and D) TUNEL stain on 14-m cryosections of E13.5 limb buds indicating interdigital cell death. Note the reduction
between digits 1 and 3 in the CKO sample. (E and F) Phospho-H3 immunofluorescence at E13.5 showing overall reduced proliferative activity in
distal region of CKO limb buds. The fluorescence images (C to F) are representative of two experiments. Note the interdigital space between digits
3 and 4 (white arrowhead). (G to L) In situ hybridization with GDF5-specific probe. Embryonic ages indicated on right, and genotypes are indicated
across the top. Note the stunted appearance of the CKO limb buds at E13.5 coinciding with a reduction in GDF5 and more widespread expression
of GDF5 at E14.5.
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and C, blue; see also Fig. 5B), while another transcription
factor, FoxC1, was upregulated (Fig. 7B and C; blue). Subse-
quent in situ hybridizations for FoxC1 (46) showed that this
gene is expressed around forming digits at E12.5, and expres-
sion is elevated in CKO limb buds, in particular in the pre-
sumptive wrist region (Fig. 7D). The largest number of differ-
entially expressed transcripts by far (23), however, was
associated with cellular cholesterol homeostasis (Fig. 7B, red)
and included transcripts encoding cholesterol synthesizing en-
zymes and sterol-sensing or transport proteins and the P450
enzyme, Cyp51 (see also Table S2 in the supplemental mate-
rial). The gene encoding the retinoic acid metabolizing P450
Cyp26a1 was also on the list, together with the gene encoding
the retinoic acid-synthesizing enzyme Raldh2 and transcription
of these genes were up- and downregulated, respectively (Fig.
7B and C, green). The 12 remaining genes identified were
either uncharacterized transcripts or unrelated to those de-
scribed above.
Deletion of POR leads to excess retinoic acid. In the absence
of POR, Cyp26 enzymes should be inactive, resulting in in-
creased retinoic acid levels in CKO forelimb buds. It has pre-
viously been shown that genes encoding both retinoid-gener-
ating and retinoid-degrading enzymes are transcriptionally
regulated by retinoic acid to maintain homeostasis (19, 66).
The changes in transcript levels of retinoic acid metabolizing
enzymes revealed by the microarray (Fig. 7B and C) therefore
suggested the elevation of retinoic acid.
We confirmed changes in expression of genes involved in
retinoic acid metabolism, Cyp26b1 and Raldh2, in CKO limb
buds at E11.5 and E12.5 using whole-mount in situ hybridiza-
tion. Cyp26b1 was chosen rather than Cyp26a1 because both
genes show essentially the same regulation (66), but Cyp26b1 is
better characterized in limb development (96), and we have
previously shown an upregulation of Cyp26a1 in POR-deficient
limb buds (67). Only minor differences were detectable at
E11.5 between control and Prx1-Cre; PORlox/lox forelimb buds
for Cyp26b1 (Fig. 8A and C), whereas Raldh2 already appeared
to be downregulated in CKO forelimbs (compare Fig. 8E and
G). At E12.5, expression patterns for both genes agreed with
the microarray results with Cyp26b1 ectopically expressed in
forelimbs (Fig. 8I and K), whereas Raldh2 expression domains
were smaller (Fig. 8M and O). There were no obvious differ-
ences in expression of either gene in hind limb buds at E11.5 or
E12.5 (Fig. 8B, D, F, H, J, L, N, and P). A three-dimensional
reconstruction of whole-mount in situ hybridization specimens
at E12.5 (Fig. 8Q to T) showed that interdigital mesenchyme
between forelimb digits 3 and 4 was the only domain with
nonoverlapping expression Cyp26b1 and Raldh2. It was devel-
opment of this interdigital space that led to the characteristic
splaying of digits 3 and 4 in CKO forelimbs (see for example,
Fig. 2A and Fig. 4F and H).
Direct retinoid measurements in E12.5 limb buds showed
elevated atRA in CKO forelimb buds, while the levels of atRA
were similar in forelimb buds of control embryos and both
CKO and control hind limb buds (Fig. 8U). The elevation of
atRA resulted in around a 50% increase in the ratio of atRA
to retinol in CKO forelimbs compared to control forelimbs in
which the ratio was similar to that in both CKO and control
hind limbs. From these results, we conclude that POR inacti-
vation led to reduced retinoic acid degradation, resulting in
accumulation of retinoic acid throughout E12.5 forelimb buds,
except probably in the interdigital space between digits 3 and 4.
POR deletion leads to impaired cholesterol metabolism.
The microarray results showed that genes encoding P450 en-
zymes involved in cholesterol metabolism, in particular Cyp51,
are expressed in the handplate of E12.5 mouse forelimbs (Fig.
7A) and, since these require POR function for their activity,
cholesterol homeostasis is predicted to be affected in CKO
limb buds. It has been previously shown that reduced choles-
terol leads to transcriptional upregulation of enzymes in the
pathway (23). Strikingly, our microarray data showed that en-
zymes of almost the whole pathway, from acetyl coenzyme A
all of the way down to cholesterol, were transcriptionally up-
regulated in CKO forelimbs (Fig. 7C and 9A, red), together
FIG. 6. Chondrogenesis in Prx1-Cre; PORlox/lox forelimb buds at
E13.5. Whole-mount in situ hybridizations for Sox9 (A and B), Col2A
(C and D), Col10 (E and F), and Ihh (G and H). (A and B) Sox9
expression in CKO limb buds showed less sharp boundaries and no
definitive joint-forming regions. (C and D) Col2A expressed in similar
pattern to Sox9. Note the extended space between digits 3 and 4 in
both expression patterns (arrowhead). (E and F) Expression of Col10
in hypertrophic chondrocytes increased at base of presumptive digits 3
and 4 but reduced in other three digits in CKO. (G and H) Ihh
expression in prehypertrophic chondrocytes resembles Col10 pattern.
The shapes and sizes—but not the locations—of both Col10 and Ihh
expression domains were variable. No variation was observed for con-
trol embryos.
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with the low-density lipoprotein receptor 1 (LDLR1) respon-
sible for cholesterol uptake (6), Stard4, the protein participat-
ing in intracellular cholesterol transport, the sterol-sensing
protein Insig1, and the sterol regulatory element binding factor
2 (SREBP2), while the gene encoding ATP-binding cassette A1
(ABCA1) involved in lipid efflux from cells (72) was downregu-
lated (Fig. 9B; see Table S2 in the supplemental material).
Furthermore, direct measurements of sterols made in E13.5
control and CKO limbs (Fig. 9C) showed that the amount of
cholesterol per CKO limb bud was reduced compared to con-
FIG. 7. Microarray analysis of E12.5 forelimb buds. (A) Transcripts of P450 enzymes in control embryos. The table shows all annotated Cyps
with present calls (detection call above background) in all five arrays, together with the substrate specificities (according to the KEGG database).
(B) Differentially expressed genes. All statistically significant probe sets with low false discovery rates represent 39 differentially expressed genes
(0.1% of all genes on array). Genes involved in cholesterol homeostasis (red), retinoic acid-metabolizing enzymes (green), transcription factors
(blue), and unknown transcripts or genes of unclassified function (yellow). The largest group (22) of upregulated genes in CKO samples is involved
in cholesterol biosynthesis. (C) Changes of each differentially expressed gene, given next to each bar. Color coding as in panel B. Upregulation
of cholesterol biosynthesis pathway indicates cholesterol deficiency through metabolic feedback. (D) In situ hybridization for FoxC1. The
expression pattern confirms microarray results.
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trol limb buds. Levels were lower in CKO forelimbs than in
CKO hind limbs, showing that differential timing of POR de-
letion still has an effect at E13.5. These data show that POR
inactivation led to cholesterol deficiency in CKO forelimbs.
Further measurements in 2-month-old mice showed that, in
CKO forelimbs, cholesterol was still reduced (87.3% in CKO
mice compared to 92.9% in controls), whereas the precursor
lathosterol had accumulated (12.7% for CKO mice versus
7.1% in controls), although the overall amounts of sterols were
similar (CKO, 2.83  0.36 mg of sterol extracted/g of extracted
oil; control, 2.50  0.54 mg/g).
We tried to rescue the forelimb phenotype by manipulating
the diet of dams, feeding them either a VAD diet to counter
retinoic acid excess, a diet supplemented with 2% cholesterol
to counter cholesterol deficiency, or a combination of both
diets. Examination of forelimbs of CKO embryos from dams
on either cholesterol supplemented or combined diet showed
that soft tissue webbing was less obvious particularly at E14.5
(Fig. 9D and data not shown [compare to Fig. 4F, inset]). In
contrast, on a VAD diet, soft tissue webbing and splaying of
digits 3 and 4 was still pronounced (data not shown). These
data are consistent with the involvement of cholesterol defi-
ciency in soft tissue syndactyly in CKO forelimbs.
DISCUSSION
We have shown that POR is required for normal develop-
ment of the limb and its skeleton. POR deficiency in humans
FIG. 8. Retinoic acid homeostasis. (A to P) In situ hybridization for Cyp26B1 (A to D and I to L) and Raldh2 (E to H and M to P). Embryonic
ages are indicated on the left, genotypes are indicated across the top, and riboprobes/methodology are indicated on the right. Hind limb buds were
included as an internal control. Very little variation was seen. Note the accumulation of Cyp26B1 transcripts in CKO forelimb buds at E12.5
(compare panels I and K) and the reduction of Raldh2 transcripts (compare panels M and O); both findings are consistent with the microarray
data (Fig. 7C). (Q to T) Optical projection tomography of E12.5 limb buds. Cyp26B1 (orange) and Raldh2 (green) expression patterns were digitally
overlaid. Note that the interdigital space between digits 3 and 4 (white arrowhead) does not show overlapping expression of these two genes (S).
(U) Quantification of atRA, retinol (ROH), and 13-cis retinoic acid (13cisRA) expressed as the mean per limb bud. Considerable variation was
seen between samples for both genotypes, irrespective of whether the forelimb or hind limb was examined. Note that the mean value for atRA
and the ratio of atRA/ROH (given as means  the standard deviation) increased in CKO forelimbs but not hind limbs, a finding consistent with
the expression patterns.
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causes disordered steroidogenesis and occasionally bone mal-
formations resembling Antley-Bixler syndrome (27). By knock-
ing out POR specifically in limb bud mesenchyme in the em-
bryo, we were able to reproduce most skeletal malformations
seen in systemic POR deficiency seen in patients, such as ab-
normal bowing of long bones, joint contractures, ankylosis, and
digital abnormalities (11, 34), with some of these features be-
ing more prominent postnatally. We saw some aspects such as
digital abnormalities in only the forelimbs of CKO embryos
although other features were seen in both forelimbs and hind
limbs. The reason for this difference is that POR deletion
occurs at an earlier stage in development and is more efficient
in the forelimbs than in the hind limbs using Prx-Cre, as has
been reported previously (49). Since the forelimb phenotype
has more of the features seen in POR deficiency in human
patients, we concentrated on analyzing the development of the
forelimbs at the molecular level. Overall, our results demon-
strate the importance of cellular metabolism and a local func-
tioning P450 system in the limb throughout development.
P450 pathways operating in limb development. Our mi-
croarray data showed that the digital plate of the developing
mouse forelimb expresses P450 enzymes participating in reti-
noic acid, cholesterol, and arachidonic acid metabolism in ad-
dition to metabolizing chemical compounds; expression of nine
of these, involving the same metabolic pathways, was also de-
tected in whole E11 mouse embryos by reverse transcription-
PCR (13). It is known from many studies that retinoic acid
metabolism and Cyp26 enzymes play major roles in embryo-
genesis, limb development, and patterning (52, 55, 61, 62, 70,
96), and the general relevance of cholesterol metabolism for
embryogenesis has also been well established (42, 89). In con-
trast, although arachidonic acid metabolism is known to con-
tain cytochrome P450-regulated steps (9, 10) and its products
have been implicated in vascular homeostasis and angiogenesis
(5, 26), little is known about the function of this pathway in
embryonic development. Thus, although Cyp enzymes involved
in arachidonic acid metabolism are expressed in the digital
plate of the forelimb, it is not clear whether inactivation of this
FIG. 9. Changes in metabolism in Prx1-Cre; PORlox/lox limb bud cells and levels of cholesterol. (A) Cholesterol biosynthesis pathway (see also
Table S2 in the supplemental material). Upregulated enzymes in CKO forelimb buds are shown (red). Note that Cyp51 as a POR-dependent
enzyme is nonfunctional despite being upregulated. (B) POR deficiency on a cellular level based on microarray results. Colors: cholesterol
metabolic pathway, red; cholesterol, red hexagons; cholesterol transport, yellow; retinoic acid metabolic pathway, green; transcription factors, blue.
(C) Cholesterol quantification in E13.5 limb buds. CKO forelimbs show reduced cholesterol levels compared to controls Values were calculated
per limb bud and represent the mean of three embryos. (D) Rescue experiment. To try and rescue the phenotype, dams were given a diet enriched
with 2% cholesterol. Embryos were prepared at E14.5 and stained for cartilage. Splaying between digits 3 and 4 was reduced (compare to Fig. 4F).
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pathway contributes to the defects. Some cytochrome P450s
from the Cyp2 family have been highlighted as potentially
interesting in a developmental context because they generate
cis-epoxyeicosatrienoic acids, which regulate a range of cellular
processes (78). Thus, for example, Cyp2c29, one of the P450s
we found to be expressed in the digital plate of the forelimb,
generates 14,15-cis-epoxyeicosatrienoic acid, which has been
shown to release a potent mitogenic growth factor in epithelial
cell lines (12).
The importance of P450-dependent pathways downstream
of POR which metabolize retinoic acid and cholesterol was
confirmed by our biochemical analyses in developing limbs. In
CKO mouse forelimbs, POR protein was markedly reduced at
E10.5 and may have already begun to impair activity of P450
enzymes. As a consequence, by E12.5 to E13.5, the retinoic
acid levels were markedly increased in CKO forelimbs, while
the cholesterol levels were decreased. In CKO hind limbs,
POR protein was still just detectable at E11.5 and retinoic acid
levels had not increased by E12.5 and, although cholesterol
levels were lower in CKO hind limbs at E13.5 compared to
wild-type limbs, this decrease was not as marked as in CKO
forelimbs.
The microarrays of CKO forelimbs at E12.5 showed changes
in the expression of a cohort of genes involved in both retinoic
acid and cholesterol pathways. These expression changes are
indicative of metabolic feedback loops being used in order to
compensate for retinoic acid excess and cholesterol deficiency,
respectively (19, 73). It is striking that a microarray performed
on the brain tissue of a cholesterol-deficient mouse (88) re-
sulted in an upregulation of genes involved in cholesterol syn-
thesis and cellular uptake, as well as a downregulation of
Abca1 (sterol efflux), very much like our results. We also found
SREBP-2 to be upregulated, which directly induces transcrip-
tion of genes involved in cholesterol synthesis and uptake (40).
Lipid metabolism, in particular sterol levels, continued to be
disturbed during the postnatal life of CKO mice. Two-month-
old CKO mice had accumulated substantial amounts of lipid in
the forepaws and still showed an unbalanced ratio in sterols.
This shows that local dysfunctional metabolism cannot be com-
pensated for by an intact liver even after birth. Further inves-
tigations will be needed to clarify whether, and to what extent,
these changes in the limbs of 2-month-old animals are a direct
consequence of embryonic cholesterol deficiency.
Contribution of metabolic pathways to forelimb defects. El-
evated retinoic acid levels might cause the stunted growth of
the distal part of the forelimb in POR-deficient mice and con-
tribute to the patterning defects in the wrist and digits. It has
been well established that the effects of excess retinoic acid on
proximo-distal patterning depend on the time of embryo ex-
posure, with earlier exposure reducing proximal elements and
later exposure reducing distal elements (47). If retinoic acid
levels are continuously elevated from the very beginning, then
all parts of the limb should be more or less equally affected, as,
for example, by functionally inactivating the retinoic acid-me-
tabolizing enzyme Cyp26b1 (96). Thus, the relatively late in-
crease in retinoic acid in Prx1-Cre; PORlox/lox forelimbs seems
consistent with defects in wrist and digits while the failure to
rescue syndactyly with the VAD diet makes it unlikely that
excess retinoic acid makes a significant contribution to this
aspect of the phenotype. How retinoic acid might cause the
patterning defects is not clear because, for example, no
changes in Hox gene expression were seen even in clearly
malformed limbs. It might be significant that the expression of
FoxC1, a gene encoding a transcription factor, shown to be
upregulated in CKO forelimb buds in our microarray experi-
ment, was enhanced particularly in the wrist region, a site of
one of these pattern defects. FoxC1 has been shown to respond
directly to retinoic acid (53), and changes in its expression have
been reported in DiGeorge syndrome (95), which is associated
with defects in retinoic acid homeostasis. Interestingly, FoxC1
has been linked to skeletal development (68) and mesodermal
cell fate choice (91), but since its function has not yet been
studied in limb development its potential contribution to the
phenotype will require further investigation.
Cholesterol deficiency is clearly implicated in soft tissue
syndactyly and the defective development of skeletal primordia
in CKO forelimbs. Thus, for example, drug-induced choles-
terol deficiency in rats leads to remarkably similar defects,
including a wide space between digits 3 and 4 and even down
to changes in the detailed expression of genes such as Ihh in
developing digits (32). The fact that a high-cholesterol diet
only slightly ameliorated the phenotype of CKO mice may be
explained by the difficulty of passing on the full amount of
cholesterol from dam to embryo since cholesterol has to be
actively transported via the placenta (92).
The proximate cause of syndactyly in CKO forelimbs ap-
pears to be the reduction of interdigital Msx2 expression, as
shown by in situ hybridization experiments and microarrays.
Msx2 normally coincides with interdigital apoptosis during limb
development (24), but in Prx1-Cre; PORlox/lox limb buds it is
reduced except between digits 3 and 4, although why this space
is spared is not clear. Interestingly, enzymes of cholesterol
biosynthesis are regionally restricted in their expression during
normal digital morphogenesis, e.g., HMG-CoA reductase ex-
pression becomes confined to interdigital zones which undergo
apoptosis at E12.5 (48).
The CKO limb phenotype has features in common with
human syndromes known to be caused by mutations in choles-
terol-synthesizing enzymes (37, 45, 85) and with the related
mouse models, even though these are all systemic disorders,
whereas our Prx1-Cre; PORlox/lox mice have a strictly peripheral
deficiency. Thus, for example, patients with Smith-Lemli-Opitz
Syndrome, caused by a mutation in 7-Dehydrocholesterol reduc-
tase, often show 2,3 toe syndactyly in addition to postaxial
polydactyly (17), while patients with mutations in either
Desmosterol reductase (25), Emopamil binding protein, or NADH ste-
roid dehydrogenase-like (CHILD syndrome or X-linked domi-
nant chondrodysplasis punctata [38, 44]) or Lamin B receptor
(90) have short limbs. In some cases, the related mouse model
has no limb defects like the Desmosterolosis model but, in
others, the mice have a wider range of limb abnormalities,
including shortening, soft tissue syndactyly, and polydactyly
(44, 89).
It has been proposed that the basis for limb defects seen
under conditions of cholesterol deficiency is due to perturba-
tion of Hedgehog signaling because cholesterol modification of
Hedgehog proteins has been shown to affect signaling range
and efficiency (reviewed in references 21, 30, and 50) and
because Sonic hedgehog (Shh) and Indian hedgehog (Ihh) are
critical for limb patterning and skeletogenesis (8, 87, 97).
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Gofflot et al. (32) suggested that syndactyly of anterior digits in
rat embryos after treatment with a cholesterol inhibitor arises
because this part of the limb bud fails to expand normally due
to changes in the range of Shh. However, inPrx1-Cre;PORlox/lox limb
buds, there is syndactyly of both anterior and posterior digits,
and the changes in cholesterol levels may occur too late to
affect Shh signaling. Therefore, syndactyly may be due to per-
turbed Ihh activity, which would also explain the reduction in
longitudinal growth of the skeletal elements in the limb (77).
We examined the expression of two genes, Patched1 and Gli1,
which are known to be transcriptionally regulated by Hedgehog
signaling and often used as reporters of hedgehog responding
cells, in E13.5 forelimbs (see Fig. S1A to D in the supplemental
material). Both expression patterns were slightly changed com-
pared to control embryos, but this may be due to altered Ihh
expression in CKO limbs (see Fig. 5H) rather than a change in the
range of Ihh signaling.
It is intriguing that Hedgehog activity has been shown to be
influenced by metabolites of all three P450 pathways (2, 16, 41,
94) identified in the limb and that alterations in retinoic acid,
cholesterol, and arachidonic acid metabolism may all converge
on Hedgehog signaling.
Implications. Through conditional POR deletion, we have
identified three P450 pathways that operate in developing limb
and skeleton. Uncovering these endogenous functions of P450s
is critical in understanding embryonic metabolism and may
also be relevant to teratogenesis. Thus, for example, it is well
established that drugs and known teratogens such as polychlo-
rinated biphenyls can alter P450 gene expression, and this
could potentially lead to inappropriate distributions of devel-
opmentally active molecules in embryos (78). Following the
suggestion about the basis for fetal alcohol syndrome (20), we
speculate that some Cyp enzymes may have higher affinities for
xenobiotic compounds than for their endogenous substrates.
Thus, an excess of xenobiotic compounds during embryogen-
esis may keep the P450 system occupied and thereby distract it
from metabolizing endogenous compounds. This could then
lead to accumulation of endogenous substrates and deficiency
of products, both of which could be manifested in disease or
malformation.
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